Weight Loss Plateau on a GLP-1? What It Means

A weight loss plateau on a GLP-1 usually means your body has reached a new balance, not that the medicine stopped working. As you lose weight, you burn fewer calories and your appetite pushes back, until what you eat matches what you burn. Check eating, protein, sleep and activity, then talk with your provider. Never raise your dose yourself.

At Padgett Medical Center in Ocala, personalized compounded semaglutide and personalized compounded tirzepatide are weekly injections with a dose your provider personalizes and adjusts over time. When your weight stalls, that dose is a question for your provider, not something to change at home.

What counts as a weight loss plateau?

A stretch of weeks when your weight trend stops falling, not one disappointing weigh-in. Researchers who studied plateaus in two large trials of FDA-approved tirzepatide note there is no agreed definition, and that a 1% to 2% change in body weight is within normal fluctuation: 2 to 4 pounds for someone who weighs 200. Judge your progress by the trend across several weeks, not a single morning.

Why does weight loss slow down on a GLP-1?

Because a smaller body needs less fuel, and your appetite fights back. A 2018 review by Kevin Hall, then a researcher at the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), and Scott Kahan cites estimates that for each kilogram (about 2.2 pounds) you lose, your body burns about 20 to 30 fewer calories a day, while appetite rises by about 100 calories a day. Hormone changes after weight loss increase hunger and reduce fullness, and the review calls appetite the likely bigger reason weight loss stalls.

A GLP-1 medicine changes how strong that pushback is, not whether it happens. In a 2024 NIDDK modeling study, Hall wrote that every obesity treatment eventually reaches a plateau, when the calories you eat rise to match the calories you burn. Fitted to average results from trials of FDA-approved semaglutide and tirzepatide, his preliminary model estimated that the two medicines, like weight-loss surgery, weakened that appetite feedback by roughly 40% to 70%. That stretches the weight-loss phase well past the roughly 12 months typical of diets. These are group averages, not a forecast for any one person.

When does a plateau usually happen on a GLP-1?

Usually after months of steady loss, and the timing varies. A 2025 advisory on nutrition during GLP-1 therapy, from four medical and nutrition societies, sums up the pattern in trials of FDA-approved GLP-1 medicines: weight comes off faster in the first 6 months, slows after that, and largely levels off at around 18 months.

How early a stall shows up depends on how a plateau is defined. The tirzepatide plateau study, funded by the medicine's manufacturer, looked back at 1,438 people in SURMOUNT-1, a 72-week trial of the FDA-approved product, who took most of their doses and lost at least 5%. Counting a plateau as losing less than 5% of body weight over 12 weeks and staying under that pace, the researchers found the median time to one ran from about 24 weeks, the earliest point they checked, to 36 weeks, depending on starting body mass index, and close to 9 in 10 had reached one by week 72. That is research on an FDA-approved product, not a result for Padgett's personalized compounded medication.

When is a plateau really the start of maintenance?

Often, when it comes after meaningful loss. The same researchers write that successful obesity treatment often has two phases, weight loss and then weight maintenance, with the plateau as the move between them and, ideally, the start of long-term maintenance. The FDA-approved labels for semaglutide and tirzepatide name both goals: to reduce excess body weight and to maintain that reduction long term.

Holding a lower weight counts. NIDDK says losing 5% to 10% of your starting weight may improve your health by lowering blood sugar, blood pressure and triglycerides, a type of blood fat. If you have lost enough weight to improve your health and have no serious side effects, it says, your health care professional may advise staying on the medication indefinitely.

A 2026 guideline from the American Heart Association, the American College of Cardiology, the American Diabetes Association and the American Society of Nephrology tells providers to counsel patients in advance about the plateau phase of obesity medication and the need to keep up lifestyle efforts. It calls GLP-1-based therapies long-term weight management strategies that require ongoing adherence.

What should you check first if your weight stalls?

Start with what you eat, because small changes are easy to miss. The Hall and Kahan review explains that appetite is regulated in parts of the brain that work below conscious awareness, so portions may creep up without your noticing, and day-to-day intake already swings by 20 to 30%. People may truly believe they are eating the same way while no longer losing, the authors write.

Try this: write down everything you eat and drink for a few days, including bites while cooking and weekend meals, and bring the notes to your provider.

Then look at protein. The 2025 advisory notes that a smaller appetite can make it hard to eat enough protein, and that low protein may add to muscle loss. It suggests eating protein-rich foods first at a meal. Protein and muscle on a GLP-1 covers how much, which foods and why.

Can sleep, stress or other medicines stall your weight loss?

They can work against it. NIDDK says not getting enough sleep may leave you hungrier, eating more calories and choosing less healthy foods. It recommends 7 to 9 hours a night for adults 18 to 64, and 7 to 8 hours from age 65. How sleep affects weight loss goes deeper.

Some medicines can make you hungrier or lower the calories your body burns. NIDDK's list includes some medicines for epilepsy, depression or psychotic disorders, corticosteroids (steroids), insulin and sulfonylureas for diabetes, some blood pressure medicines such as beta-blockers, and some allergy antihistamines. Hypothyroidism, an underactive thyroid, and long-term stress are on its list too; see thyroid problems and weight gain.

Never stop or change a prescribed medicine on your own: ask the clinician who prescribed it, and tell your weight-loss provider about every new or changed prescription.

What role does activity play once weight loss slows?

It helps protect your muscle and goes along with keeping weight off. The 2025 advisory says GLP-1 medicines should be prescribed together with a structured exercise program: strength training at least 3 times a week plus at least 150 minutes of moderate aerobic exercise weekly, to preserve muscle and bone, matched to your fitness level. Among the behaviors it links to long-term weight maintenance is physical activity of 60 minutes a day or more.

New to strength training, or living with a heart, joint or other health problem? Ask your provider what is safe for you first. Daily habits that help on a GLP-1 has more.

Should your dose go up when your weight stalls?

Not automatically, and that decision belongs to your provider. When choosing a maintenance dose, the FDA-approved labels for semaglutide and tirzepatide tell prescribers to weigh how well the medicine is working and how well it is tolerated, and each label sets a maximum dose. In the FDA-approved tirzepatide label's pooled studies, more people stopped treatment over digestive side effects at higher doses, so a higher dose is a trade-off, not an automatic fix; see personalized compounded tirzepatide doses, explained.

A plateau after good progress also differs from not responding. The 2026 guideline addresses insufficient weight loss, meaning less than 5%: it says to reassess response within 3 to 6 months of starting and, when loss falls short, to consider a dose increase, a switch to another medicine or a referral to a weight-management specialist.

Either way, never take extra injections, change your schedule or skip doses to push past a stall. Call the clinic instead. If a change of medicine comes up, switching from personalized compounded semaglutide to personalized compounded tirzepatide explains what your provider weighs.

How does plateau follow-up work at Padgett in Ocala?

Your plan is reviewed with Sarah Weir, APRN, an advanced practice registered nurse, in person at 200 SW 8th St., Suite A, just south of downtown Ocala, or by telehealth anywhere in Florida while you are physically in Florida. Care is medically supervised. Bring your weekly weights, a few days of food notes, your sleep and activity, any side effects and any medicine changes. Between visits, call the clinic at (352) 369-0104, Monday to Friday, 9:00 AM to 5:00 PM.

Pricing is by dose, so if your provider changes your dose, your monthly price follows it. Personalized compounded semaglutide is $149 a month at the starting dose, and personalized compounded tirzepatide is $229; each service page lists the other doses. The monthly price is your medication. Your provider visit is $100 and is free when you start medication at that visit; the only other charge is a $50 no-show fee. There is no contract.

New to Padgett? Book a weight-loss visit online; nothing is charged when you book. Questions first? Ask for a free 15-minute phone call with the medical staff; it is not a visit with the provider and nothing is prescribed on it.

Personalized compounded semaglutide and personalized compounded tirzepatide are compounded drugs that have not been approved by the FDA. They have not been reviewed by the FDA for safety, effectiveness, or quality. FDA-approved products containing semaglutide and tirzepatide are available. Individual results vary.

This article is educational and is not medical advice. Talk with a licensed provider about your own health, medications and treatment options.